Alveus Pharmaceuticals Private Limited, a struck off private limited company, was established on 16 October 2009 in Hyderabad, Telangana, India. Engaging in accounting and financial analysis within the professional, scientific and technical sector, it holds CIN: U24232TG2009PTC065531. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.25 Cr and a paid-up capital of ₹1.41 M.
It upholds a compliant status. Its leadership includes Komala Devi Vankayalapati (Director), Srinivasa Rao Vankayalapati (Whole-Time Director). Past directors included Hariprasad Vankayalapati, Vankayalapati Ramaiah, Vivekananda Reddy Konda. Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at Flat No: 201,3-5-83/7,Virupas Mithila Apartment Vivekananda Nagar Colony, Kukatpally, Hyderabad, Telangana, 500072.
U24232TG2009PTC065531
065531
16 October 2009
₹1.25 Cr
₹1.41 M
Roc Hyderabad
Unlisted
Struck Off
Explore comprehensive insights into Alveus Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Komala Devi Vankayalapati | Director | 05 Jan 2022 | Current |
| Srinivasa Rao Vankayalapati | Whole-Time Director | 20 Dec 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 05 Apr 2019 | Past |
| Pramod Abcsdd | Director | 01 Mar 2011 | Past |
| Pramod Abcsdd | Director | 20 Dec 2010 | Past |
| Pramod Abcsdd | Director | 17 May 2010 | Past |
| Pramod Abcsdd | Director | 06 Jan 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Alveus Pharmaceuticals Private Limited, for the financial year ended 2016, experienced significant growth in revenue, with a 85.29% increase. The company also saw a substantial fall in profitability, with a 45.96% decrease in profit. The company's net worth Soared by an impressive increase of 144.34%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Alveus Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Alveus Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Alveus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alveus Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Komala Devi Vankayalapati was appointed as a Director was appointed as a Director on 05 Jan 2022 & has been associated with this company since 4 years 12 days . was documented.
Alveus Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was recorded as a recent event.
Progress on Alveus Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Hyderabad. was documented.
Srinivasa Rao Vankayalapati was appointed as a Whole-time director was appointed as a Whole-time director on 20 Dec 2010 & has been associated with this company since 15 years 29 days . was recorded as a recent event.
Alveus Pharmaceuticals Private Limited was registered on 16 Oct 2009 with Roc Hyderabad & aged 16 years 3 months as per MCA records. was recorded as a recent event.
The CIN of Alveus Pharmaceuticals Private Limited is U24232TG2009PTC065531.
Alveus Pharmaceuticals Private Limited is headquartered at Flat No: 201,3-5-83/7,Virupas Mithila Apartment Vivekananda Nagar Colony, Kukatpally, Hyderabad, Telangana, 500072.
Alveus Pharmaceuticals Private Limited was incorporated on 16 October 2009.
The current directors of Alveus Pharmaceuticals Private Limited are
The primary industry of Alveus Pharmaceuticals Private Limited is Professional, Scientific And Technical.
Alveus Pharmaceuticals Private Limited is unlisted.
The authorized capital of Alveus Pharmaceuticals Private Limited is ₹1.25 Cr, and the paid-up capital is ₹1.41 M.
The compliance status of Alveus Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX